The Therapeutic Arsenal: Treatment and Demographic Dynamics in the Fabry Disease Market
The Fabry Disease Market is characterized by a dynamic interplay of established and emerging therapies, each catering to different patient needs and shaping the market's growth. Valued at USD 2.44 billion in 2024 and projected to reach USD 5.58 billion by 2035, the market's expansion is closely tied to the evolution of its core segments. The treatment landscape is led by Enzyme...
0 Comments 0 Shares 43 Views 0 Reviews